Back to Screener

Communication Services

Cardlytics Inc(CDLX)

Live Price

Offline

$5.04

-5.97% today

Window Change

+574.21%

Window

May 6, 2026 โ†’ Jun 24, 2026

Market Cap
$50.00M
Revenue Growth
-16.2%
EPS Growth
+50.1%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 34 bars ยท May 6, 2026 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Cardlytics Inc (CDLX) is a Communication Services stock with a market cap of $50.00M and listed on NASDAQ. The stock last traded around $5.04 and up 574.2% across the available one-year price window (May 6, 2026 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of -16.2%, EPS growth of +50.1%, a dividend yield of 0.0%. What stands out right now is revenue -16.2%, EPS +50.1%, free cash flow +131.3% with operating margin -43.4% and ROIC -48.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CDLX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Communication Services peers on this page.

Benchmark Edge

CDLX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CDLX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CDLX Max Drawdown

-34.71%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CDLX and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Cardlytics Inc (CDLX)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$267.1M

-10.5% YoY

FY Net Income

-$128.6M

+72.4% YoY

Free Cash Flow

-$51.1M

+24.2% YoY

Revenue Growth

-16.2%

EPS Growth

+50.1%

Gross Margin

45.0%

Net Margin

-44.4%

Income statement

USD

Annual
Metric20252024202320222021
Revenue233M278M309M299M267M
Gross Profit105M121M130M113M103M
Operating Income-47M-195M-136M-458M-123M
EBITDA-20M-153M-99M-420M-88M
Net Income-103M-189M-135M-465M-129M
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

USD

Point-in-time
Metric20252024202320222021
Cash & Equivalents49M66M92M122M233M
Total Assets286M393M574M691M1.3B
Total Liabilities292M323M439M480M573M
Shareholder Equity-7M70M135M212M691M
Total Debt215M222M266M235M197M
Net Debt167M156M174M113M-36M

Cash flow positioning

Latest Full Year

Operating Cash Flow

39M

+28.5% YoY

Capital Expenditures

13M

+6.8% YoY

Free Cash Flow

51M

+24.2% YoY

Key ratios

  • Gross Margin

    45.0%

  • Operating Margin

    -43.4%

  • Net Margin

    -44.4%

  • ROE

    -371.0%

  • Debt / Equity

    -33.08x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.